Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

VNDA Vanda Pharmaceuticals

9.880
+0.110+1.13%
Close 09/30 16:00 ET
9.8800.0000.00%
Post Mkt Price 09/30 16:22 ET
High
10.100
Open
9.800
Turnover
4.10M
Low
9.770
Pre Close
9.770
Volume
413.87K
Market Cap
558.83M
P/E(TTM)
52.00
52wk High
21.440
Shares
56.56M
P/E(Static)
17.03
52wk Low
9.240
Float Cap
511.44M
Bid/Ask %
-60.00%
Historical High
33.440
Shs Float
51.77M
Volume Ratio
1.00
Historical Low
0.450
Dividend TTM
--
Div Yield TTM
--
P/B
1.10
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.80%
Amplitude
3.38%
Avg Price
9.901
Lot Size
1
Float Cap
511.44M
Bid/Ask %
-60.00%
Historical High
33.440
Shs Float
51.77M
Volume Ratio
1.00
Historical Low
0.450
Dividend TTM
--
P/B
1.10
Dividend LFY
--
Turnover Ratio
0.80%
Amplitude
3.38%
Avg Price
9.901
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.
CEO: Dr. Mihael Hristos Polymeropoulos,M.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...